CRG
PE
2003
$4 000 M
Houston, Texas, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
CRG is a premier healthcare-focused investment firm that has managed over $3 billion of institutional capital since inception and its senior investment professionals have led over 70 investments. The firm seeks to commit between $20 to $300 million in each investment across the healthcare spectrum, including: medical devices, biopharmaceuticals, tools & diagnostics, services and information technology. CRG provides growth capital in the form of long-term debt and equity to support innovative, commercial-stage healthcare companies that address large, unmet medical needs. The firm partners with public and private companies to provide flexible financing solutions and world-class support to achieve exceptional growth objectives with minimal dilution. CRG maintains offices in Boulder, New York and Houston. For additional information, please visit www.crglp.com.
Industry
Region of investment
CRG Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Capital Royalty Partners II
|
Private Equity (PE)
|
Healthcare Services
Medical Devices
Life Sciences
|
Series B
Late Stage (Series C+)
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$805 M
|
May 2013
|
|
CRG Partners III
|
Private Equity (PE)
|
Healthcare Services
Medical Devices
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1500 M
|
January 2017
|
|
CRG Partners I LP
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$325 M
|
June 2003
|
|
CRG Partners IV LP
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1400 M
|
November 2017
|
